As the sole U.S. supplier of fluoxymesterone, Upsher-Smith sought a way to renew the product’s availability after the company’s initial API manufacturer discontinued its supply.
In a move that will reshape the generic pharmaceuticals landscape, Teva announced Monday that it would be acquiring Allergan Generics for $40.5 billion.
The Food and Drug Administration announced Friday that it had approved Novartis’ Odomzo (sonidegib). The drug is meant to treat basal cell carcinoma, the most common form of advanced skin cancer.
On Friday, Stichting Preferred Shares Mylan, an independent foundation established in the Netherlands, announced that it would exercise its full call option to purchase 488,388,431 preferred shares in Mylan.
The council for Responsible Nutrition has 13 new member companies, including nine associate members and four new voting members.
Pharmabox seeks input from future potential customers on where they'd like to see the next OTC kiosk.
Qore-24 creates an antimicrobial barrier on the hand for up to 24 hours, according to the company.
Access to healthcare drove 82.9% more blood pressure screenings and 26.9% more diabetes screenings.
The National Sleep Foundation will host the inaugural Sleep Technology Summit & Expo Oct. 6-7 in Santa Clara, Calif.
Patients surfing the content on Elsevier's Health Library can search by a specific condition or diagnosis or move through an easy-to-skim, A-to-Z list of healthcare topics.